Application 021375

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ALAVERTLORATADINETABLET, ORALLY DISINTEGRATING;ORAL10MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021375-001ALAVERTLORATADINE10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d4dbc9d85df4…
2026-10-15 13:18:302026-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c2088c7a36db…
2026-09-14 22:38:342026-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1984e616aacf4f…
2026-08-18 06:07:402026-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1974a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1987673890dc5c…
2021-03-12 10:30 UTC2021-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f01610625f2…
2019-09-15 20:21 UTC2019-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b00525d2431f…
2019-07-19 19:46 UTC2019-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-199b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f0d92c62455…
2023-05-13 08:27 UTC2023-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19053a50430f4f…
2023-01-26 05:58 UTC2023-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 12 of 17 · 338 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Loratadine antihistamineLORATADINEAphena Pharma Solutions - Tennessee, LLCa2c92766-df4e-4414-9c42-e18bcf9db6b42024-04-09WarningsName fallback
generic name: LORATADINE
Loratadine Allergy ReliefLORATADINEBryant Ranch Prepack40914eeb-3a85-4691-9fb8-2df72ba1f7092024-04-05WarningsName fallback
generic name: LORATADINE
Loratadine Allergy ReliefLORATADINEBryant Ranch Prepack94642b79-f91a-429f-87f4-dad326d4f3ed2024-04-03WarningsName fallback
generic name: LORATADINE
good sense allergy reliefLORATADINEA-S Medication Solutionsc288d849-59c9-4883-aac4-bae54acee8ac2024-03-27WarningsName fallback
generic name: LORATADINE
DYE-FREE CHILDRENS LORATADINELORATADINEOhm Laboratories Inc.10b0e325-335b-05b6-e063-6394a90a8c2f2024-03-15WarningsName fallback
generic name: LORATADINE
Dye-Free Childrens LoratadineLORATADINEOhm Laboratories Inc.9e9b2e1c-f565-42ef-9ec4-43bcebc549b72024-03-15WarningsName fallback
generic name: LORATADINE
Dye-Free Childrens LoratadineLORATADINECVS PHARMACY, INC0b78fed4-69eb-f66f-e063-6294a90a3b892024-03-15WarningsName fallback
generic name: LORATADINE
CHILDRENS LORATADINELORATADINESAFEWAY0e0fbbf7-a42e-e101-e063-6294a90a69772024-03-15WarningsName fallback
generic name: LORATADINE
Wal-itinLORATADINEWALGREENS CO.fb9608d9-b401-40d9-aff3-2bc0dc6e92d82024-03-15WarningsName fallback
generic name: LORATADINE
DYE-FREE CHILDRENS LORATADINELORATADINEPUBLIX SUPER MARKETS, INC0b29afdc-3b0f-3958-e063-6394a90a233a2024-03-15WarningsName fallback
generic name: LORATADINE
members mark allergy reliefLORATADINESam's West Inc95c2b45a-d0e5-467c-aad4-7bbb6c9a52042024-03-11WarningsName fallback
generic name: LORATADINE
good sense allergy reliefLORATADINEA-S Medication Solutions5fda4906-4133-4293-8b39-4ddcf8d398012024-02-04WarningsName fallback
generic name: LORATADINE
kirkland signature allerclearLORATADINECostco Wholesale Company2074d52e-8c0a-4e69-bfb1-864ffc07e25f2024-01-17WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINEWal-Mart Stores, Incf62c48ab-8dd3-4ed1-a123-d478efe8e8392024-01-11WarningsName fallback
generic name: LORATADINE
DYE-FREE CHILDRENS LORATADINELORATADINEWAL-MART STORES, INC01d6de60-58b0-453f-a0be-95146ce29ea32024-01-11WarningsName fallback
generic name: LORATADINE
Childrens LoratadineLORATADINEOhm Laboratories Inc.c088c998-d823-4bd0-9382-b567221f85a72024-01-11WarningsName fallback
generic name: LORATADINE
LORATADINE ALLERGY RELIEF 10mgLORATADINEYYBA CORPdcb63e1b-d499-2e84-e053-2995a90af5c72024-01-03WarningsName fallback
generic name: LORATADINE
ALLERGY RELIEF 10mgLORATADINEYYBA CORP6103cf98-40b1-4d27-8eb7-6f6a069497302024-01-03WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINETenshi Kaizen Pvt Ltdc20b91e0-ef92-6f2f-e053-2a95a90a2a362024-01-02WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINECVS PHARMACY, INC7ed2aec0-4da7-4edc-9998-b96c67c827382024-01-02WarningsName fallback
generic name: LORATADINE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0573-2620ALAVERT ALLERGYloratadineGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-2620ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2620ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
80070-110AlavertLORATADINEFoundation Consumer BrandsNDACurrent
80070-120AlavertLORATADINEFoundation Consumer BrandsNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
27639SUPPL2005-08-23
5224ORIG2004-05-26
42129ORIG2004-03-24
36796ORIG2003-04-09